Therapy of small cell lung cancer with emphasis on oral topotecan

Abstrakt

Systemic chemotherapy plays a major role in the management of patients with small cell lung cancer. In the second-line setting, topotecan showed similar efficacy but better tolerability compared to combination chemotherapy and similar efficacy showed oral and venous formulations.

Klíčová slova

• chemotherapy
• new drugs
• thoracic radiotherapy
• brain irradiation
• second-line therapy
• Topotecan